Convert your Lanreotide dose
Vial
Result
Converted amount60,000 mcg
Dose mass60,000 mcg
Concentration2,500 mcg/mL
Draw volume24 mL
U-100 syringe2,400 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| acromegaly | subcutaneous | 60–120 mg | every 4 weeks |
| GEP-NET / carcinoid | subcutaneous | 120–120 mg | every 4 weeks |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 60,000 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 30 mL | 3,000 units | 0 |
| 2 mg | 2 mL | 60 mL | 6,000 units | 0 |
| 2 mg | 3 mL | 90 mL | 9,000 units | 0 |
| 5 mg | 1 mL | 12 mL | 1,200 units | 0 |
| 5 mg | 2 mL | 24 mL | 2,400 units | 0 |
| 5 mg | 3 mL | 36 mL | 3,600 units | 0 |
| 10 mg | 1 mL | 6 mL | 600 units | 0 |
| 10 mg | 2 mL | 12 mL | 1,200 units | 0 |
| 10 mg | 3 mL | 18 mL | 1,800 units | 0 |
Calculated for the low end of the reported acromegaly range. Change the dose in the calculator above for any other amount.
Lanreotide at a glance
~23–30 days (depot formulation)
Half-life
1,096.32 Da
Molecular weight
subcutaneous, intramuscular
Routes
prescription
Legal status